BlinkLab has reported results from its European case-control study evaluating smartphone-based digital neurobehavioural biomarkers for ADHD detection in children aged six through seventeen years. The study achieved eighty-two percent sensitivity and eighty-three percent specificity against a clinical diagnostic reference standard, providing the first evidence that BlinkLab's biomarker platform can detect differences associated with ADHD.